Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.005 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |